IP Library › Patent Application 18076777
Patent Application
App. No. 18/076,777

INTEGRATED PACKAGE FOR ADMINISTRATION OF LYOPHILIZED MEDICINES

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/076,777
Abstract

An auto-disable prefillable integrated package apparatus includes a first chamber, a second chamber, a connection configured to form a communicable channel between the first chamber and the second chamber, a frangible membrane configured to form a rupturable barrier within the connector that separates the first chamber and the second chamber, and a hub configured to be communicably coupled to the second chamber.

Claims (37)

1 . An auto-disable prefillable integrated package apparatus, comprising:

a first chamber;

a second chamber;

a connection configured to form a communicable channel between the first chamber and the second chamber;

a frangible membrane configured to form a rupturable barrier within the connector that separates the first chamber and the second chamber; and

a hub configured to be communicably coupled to the second chamber.

2 . The auto-disable prefillable integrated package apparatus of claim 1 , wherein the second chamber comprises a compressible inner volume.

3 . The auto-disable prefillable integrated package apparatus of claim 1 , further comprising a valve configured to prevent fluid flow from the second chamber into the first chamber via the connector.

4 . The auto-disable prefillable integrated package apparatus of claim 1 , further comprising a needle assembly configured to be communicatively coupled to the hub.

5 . The auto-disable prefillable integrated package apparatus of claim 1 , further comprising a bonded periphery.

6 . The auto-disable prefillable integrated package apparatus of claim 1 , wherein the frangible membrane is configured to rupture when a mechanical force above a rupture threshold is applied by a user to the connector.

7 . The auto-disable prefillable integrated package apparatus of claim 1 , wherein the hub comprises a port.

8 . The auto-disable prefillable integrated package apparatus of claim 3 , wherein the valve comprises a disc valve.

9 . The auto-disable prefillable integrated package apparatus of claim 1 , wherein the frangible membrane comprises a polymer compound.

10 . A multi-chamber integrated package apparatus, comprising:

a first chamber;

a second chamber;

a third chamber;

a first connector configured to form a communicable channel between the first chamber and the third chamber;

a second connector configured to form a communicable channel between the second chamber and the third chamber;

a first frangible membrane configured to form a rupturable barrier within the first connector separating the first chamber and the third chamber;

a second frangible membrane configured to form a rupturable barrier within the second connector separating the second chamber and the third chamber; and

a hub configured to be communicatively coupled to the third chamber.

11 . The multi-chamber integrated package apparatus of claim 10 , wherein the third chamber is configured to have a compressible inner volume.

12 . The multi-chamber integrated package apparatus of claim 10 , wherein the third chamber is configured to contain a lyophilized drug product.

13 . The multi-chamber integrated package apparatus of claim 12 , wherein the first chamber is configured to contain a reconstitution solution.

14 . The multi-chamber integrated package apparatus of claim 12 , wherein the second chamber is configured to contain a reconstitution solution.

15 . The multi-chamber integrated package apparatus of claim 10 , further comprising a needle assembly configured to be communicably coupled to the hub.

16 . The multi-chamber integrated package apparatus of claim 10 , wherein the first frangible membrane and the second frangible membrane are configured to rupture when a mechanical force above a rupture threshold is applied by a user to the corresponding one of the first connector and the second connector.

17 . A syringe-type integrated package apparatus, comprising:

a cylindrical body having a first chamber and a second chamber separated by a frangible membrane;

a plunger assembly;

a hub communicably coupled to the second chamber; and

a needle assembly configured to be communicably coupled to the hub.

18 . The syringe-type integrated package apparatus of claim 17 , wherein the frangible membrane is configured to rupture when a mechanical force above a rupture threshold is applied by a user to the plunger assembly in a direction that presses the plunger assembly into the cylindrical body.

19 . The syringe-type integrated package apparatus of claim 17 , wherein the first chamber is configured to contain a reconstitution solution.

20 . The syringe-type integrated package apparatus of claim 17 , wherein the second chamber is configured to contain a lyophilized drug product.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 19, 2026
From: HELDEBRANT, CHARLES, DR.
To: PSC BIOTECH CORPORATION
Reel/Frame 073508/0011 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 19, 2026
From: CLAPHAM, ANDREW JOHN
To: PSC BIOTECH CORPORATION
Reel/Frame 073508/0086 →